Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|10|1923-1955

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.10, 2013-03, pp. : 1923-1955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combretastatin A-4 Analogs as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-12 ,pp. : 1186-1205

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrupting Agents: An Overview of New Derivatives of Natural Combretastatin A-4

By  

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 3035-3081

Bentham Science Publishers

Access to resources Recommend Favorite

Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

By  

Current Medicinal Chemistry, Vol. 22, Iss. 11, 2015-04 ,pp. : 1348-1360

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Zhao Liangli   Marshall Elaine   Kelland Lloyd   Baguley Bruce  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 271-276

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation Of 5-hydroxy-2,3-diaryl (substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anti angiogenic and anticancer agents

By Sanna Vinod   Jaggi Manu   Kumar Vadlapudi   Burman Anand  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 363-380

Springer Publishing Company

Access to resources Recommend Favorite